Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins. To boost ...

In this interview, Technology Networks talked to Dr. Stacy Lindborg, president, chief executive officer and board member at IMUNON, Inc., who shares how its PlaCCine® platform could reshape vaccine ...

Mouse cells tweaked to produce the tardigrade protein incurred less DNA damage than unaltered cells — hinting at a new tool for cancer patient care.

NIH-supported researchers have developed a new method using a protein from tardigrades to help protect healthy tissue during ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

Scientists would examine the DNA and RNA (RNA and mRNA serve different functions in a cell) of a specific patient's tumor to create a vaccine to teach that person's immune system to target and ...

Sungyul Lee, PhD, principal scientist and lab leader at Bio R&D, Samsung Biologics Therapeutic mRNA manufacturing begins with in vitro transcription, in which plasmid DNA (or pDNA) is linearized ...

For years, scientists worldwide have been experimenting with messenger RNA (mRNA) vaccines, unable to secure the funding or ...

New method uses DNA barcodes for high throughput RNA and protein detection in deep tissue. ScienceDaily . Retrieved March 28, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250311121315.htm ...